Friday, 26 April 2019

Generics News

  • Teva launches generic AndroGel

    Generics |  News | 0 Comment | 22 Apr, 2019

    Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of AndroGel ®i (testosterone gel) 1.62% CIII in the U.S. Testosterone Gel 1.62% CIII is indicate...Read more

  • Teva announces launch of generic version of EXJADE®

    Generics |  News | 0 Comment | 25 Mar, 2019

    Teva Pharmaceutical has announced the launch of a generic version of EXJADE®1 (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S. Deferasirox Tablets...Read more

  • FDA accepts NDA for Lemborexant to treat Insomnia

    Generics |  News | 0 Comment | 12 Mar, 2019

    Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma, L.P. have announced that the U.S. Food and Drug Administ...Read more

  • Vitruvias, Sinotherapeutics launch approved version of Propafenone ER in the U.S.

    Generics |  News | 0 Comment | 11 Mar, 2019

    Vitruvias Therapeutics Inc., an Auburn, Alabama-based finished-dose generic drug company, and Sinotherapeutics Inc., a Shanghai-based generic drug company, have launched a bioequivalent FDA...Read more

  • CHMP backs Sanofi's Dupixen in asthma

    Generics |  News | 0 Comment | 08 Mar, 2019

    Regeneron Pharmaceuticals and Sanofi recently announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...Read more

  • Lupin receives FDA approval for generic version Vidaza

    Generics |  News | 0 Comment | 01 Mar, 2019

    Pharma major Lupin announced that it has received approval for its Azacitidine for Injection, 100 mg Single-Dose Vial from the United States Food and Drug Administration (FDA) to market a g...Read more

  • Novartis receives FDA approval for Egaten

    Generics |  News | 0 Comment | 20 Feb, 2019

    Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This mak...Read more

  • Lupin launches Tadalafil Tablets

    Generics |  News | 0 Comment | 13 Feb, 2019

    Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Tadalafi...Read more

  • Lupin receives FDA approval for Fluoxetine Tablets

    Generics |  News | 0 Comment | 13 Feb, 2019

    Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States Food and Drug Administration (FDA) to market a generic version of Alv...Read more

  • Lupin announces launch of NaMuscla

    Generics |  News | 0 Comment | 04 Feb, 2019

    India based pharma company Lupin has announced the launch of NaMuscla® (mexiletine) in Germany and the United Kingdom (UK). NaMuscla® is approved across the European Union (EU) for ...Read more

  • Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval

    Generics |  News | 0 Comment | 01 Feb, 2019

    Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of ADVAIR DISKUS. Wixel...Read more

  • Cipla receives approval for Pfizer’s Depo-Provera

    Generics |  News | 0 Comment | 28 Jan, 2019

    Global pharma company, Cipla has announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Medroxyprogesterone Injectable, 150mg/mL from the United S...Read more

  • Glenmark receives tentative ANDA approval for Topiramate

    Generics |  News | 0 Comment | 24 Jan, 2019

    Glenmark Pharmaceuticals Inc., has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Topiramate Extended-Release Capsules, 25 mg, 50 mg, 100...Read more

  • Lupin receives FDA approval for Levothyroxine Sodium Tablets

    Generics |  News | 0 Comment | 22 Jan, 2019

    Indian Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 mcg, 75 mcg,  88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg...Read more

  • J&J completes acquisition of Ci:z Holdings

    Generics |  News | 0 Comment | 18 Jan, 2019

    Johnson & Johnson has announced the completion of the acquisition of Ci:z Holdings Co., Ltd. for a total purchase price of approximately ¥230 billion. The acquisition was completed...Read more

  • Aurobindo Pharma’s subsidiary to acquire products from Spectrum Pharma

    Generics |  News | 0 Comment | 18 Jan, 2019

    Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also...Read more

  • Lupin’s NaMuscla receives EC Approval

    Generics |  News | 0 Comment | 08 Jan, 2019

    Lupin has announced that the European Commission (EC) has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorder...Read more

  • Hetero Labs limited acquires Tarbis Farma

    Generics |  News | 0 Comment | 02 Jan, 2019

    Telangana based Pharma company, Hetero has announced that its European subsidiary Amarox Limited has acquired Tarbis Farma, S.L.U., a company operating in Spain from Grupo Ferrer Internacio...Read more

Podcast

 

Survey Box

Can data align the pharma industry with healthcare better?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls